Search details
1.
Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med
; 389(24): 2245-2255, 2023 Dec 14.
Article
in English
| MEDLINE | ID: mdl-38091531
2.
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Ann Intern Med
; 177(2): 189-195, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38190712
3.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis
; 78(3): 746-755, 2024 03 20.
Article
in English
| MEDLINE | ID: mdl-37972288
4.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Article
in English
| MEDLINE | ID: mdl-37633258
5.
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med
; 385(15): 1355-1371, 2021 10 07.
Article
in English
| MEDLINE | ID: mdl-34496194
6.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep
; 73(12): 271-276, 2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38547037
7.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(8): 180-188, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38421945
8.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis
; 228(2): 185-195, 2023 07 14.
Article
in English
| MEDLINE | ID: mdl-36683410
9.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-36415904
10.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis
; 227(12): 1348-1363, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-36806690
11.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis
; 2023 Dec 02.
Article
in English
| MEDLINE | ID: mdl-38041853
12.
Impact of a scalable training program on the quality of colonoscopy performance and risk of postcolonoscopy colorectal cancer.
Gastrointest Endosc
; 98(4): 609-617, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37094690
13.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Article
in English
| MEDLINE | ID: mdl-37227984
14.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep
; 72(33): 886-892, 2023 Aug 18.
Article
in English
| MEDLINE | ID: mdl-37590187
15.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Article
in English
| MEDLINE | ID: mdl-36921274
16.
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
N Engl J Med
; 390(12): 1156, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38507772
17.
Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults.
J Intern Med
; 292(2): 377-384, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35531712
18.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Article
in English
| MEDLINE | ID: mdl-36580430
19.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Article
in English
| MEDLINE | ID: mdl-36264840
20.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 139-145, 2022 Jan 21.
Article
in English
| MEDLINE | ID: mdl-35085224